Tag: Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Regulatory Science Strategy to 2025 in the EU

EMA has published its Regulatory Science Strategy to 2025. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It come...

Pre-clinical Trials of the Russian Vaccine’s Specific Activity Will Be Held before June 22

lab research
Russia will complete pre-clinical trials of the vaccines against the novel coronavirus (COVID-19) developed at the Vector State Research Center of Virology and Biotechnology in Novosibirsk before June...

Development of Cure for Coronavirus from Survivors’ Blood to Take 30 Days

lab research
Scientists from Russian Academy of Sciences’ Institute of Chemical Biology and Fundamental Medicine are ready to develop a coronavirus cure, based on coronavirus survivors’ blood, in 30 days, the Inst...

Update EMA on Treatments and Vaccines against COVID-19 under Development

vaccines
EMA’s COVID-19 response team has been in contact with developers of around 40 therapeutic medicines, allowing better understanding of potential treatments. However, at this point, on the basis of the ...

New Collaboration to Discover and Develop New Immunometabolic Medicines

Eli Lilly and Company announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying the...

FUJIFILM Corporation is Providing Correct Information Regarding Avigan Tablet

Avigan Tablet was approved for manufacture and sale in Japan in 2014 as an influenza antiviral drug. The drug is to be considered for use only when there is an outbreak of novel or re-emerging influen...

Russian Supercomputer Allow to Speed up Drug Development

Researchers working on means of COVID-19 coronavirus diagnostics and treatment have been granted priority access to the upgraded supercomputer of the Inter-Agency Supercomputer Center of Russian Acade...

AI Finds Potential COVID-19 Drugs that Can Be Used on Humans Immediately

Gero, the leader in AI-driven drug discovery, has used its AI platform to identify the potential anti-COVID-19 agents that have been previously tested on humans. Six of them have been approved, three ...

We May Have a Vaccine When the Infection is Already Ove

Scientists in several countries, including China, Russia and the United States, are pushing ahead with research into a vaccine against the novel coronavirus, but the results of their work may become a...

CytomX and Astellas Announce Collaboration to Develop Therapies for Treatment of Cancer

biotech-lab
CytomX Therapeutics, Inc. and Astellas Pharma Inc. announced they have entered into a strategic collaboration agreement focused on the discovery, research, development and commercialization of novel T...

The Clinical Trials Market Is Booming in the APAC Region

clinical-trial
The Asia-Pacific (APAC) has emerged as the most prominent region for conducting clinical trials, accounting for over 40% of the annual share of globally conducted clinical trials in 2019, finds Global...

STING Antagonists Offer Tremendous Potential for New Treatments

Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, announced a research collaboration and license agreement for Curadev’s Stimulator of Interferon Genes (STING) antagonist program. ...

China has developed eight types of vaccines against the novel coronavirus

Some of them have already proven to be effective on animals, head of the Institute of Laboratory Animal Science of the Chinese Academy of Medical Sciences Qin Chuan informed during a briefing. "Curre...

AbCellera and Lilly Will to Co-develop Antibody Products for the Treatment of COVID-19

AbCellera and Eli Lilly and Company announced they have entered into an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease caused by the SARS-CoV-2 nov...

EMA Can Give Developers Prompt Guidance on the Best Methods to Generate Drugs for COVID-19

EMA provides full fee waivers for scientific advice applications from developers of potential therapeutics (to treat the disease) or vaccines (to prevent the disease) against the novel coronavirus dis...

Manufacturing of Antibodies to Potentially Treat COVID-19

Vir Biotechnology, Inc. announced that it has signed a letter of intent with Biogen Inc. for the development and clinical manufacturing of human monoclonal antibodies for the potential treatment of CO...